Although the ALG6 gene malfunction may play a role in the poor prognosis of melanoma, we also showed that the mutation rate of ALG6 in melanoma tissues was less than 2.56%, and thus the overall expression levels of ALG6 in melanoma tissues are more likely to be affected by SNPs. The gene discussed is ALG6; the disease is melanoma.